Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 218

1.

Perspectives on the first randomized sham-controlled trial of stellate ganglion block for hot flashes.

Pinkerton JV, Wilson CS.

Menopause. 2014 Aug;21(8):788-91. doi: 10.1097/GME.0000000000000295. No abstract available.

PMID:
24983275
[PubMed - in process]
2.

Identifying the science and technology dimensions of emerging public policy issues through horizon scanning.

Parker M, Acland A, Armstrong HJ, Bellingham JR, Bland J, Bodmer HC, Burall S, Castell S, Chilvers J, Cleevely DD, Cope D, Costanzo L, Dolan JA, Doubleday R, Feng WY, Godfray HC, Good DA, Grant J, Green N, Groen AJ, Guilliams TT, Gupta S, Hall AC, Heathfield A, Hotopp U, Kass G, Leeder T, Lickorish FA, Lueshi LM, Magee C, Mata T, McBride T, McCarthy N, Mercer A, Neilson R, Ouchikh J, Oughton EJ, Oxenham D, Pallett H, Palmer J, Patmore J, Petts J, Pinkerton J, Ploszek R, Pratt A, Rocks SA, Stansfield N, Surkovic E, Tyler CP, Watkinson AR, Wentworth J, Willis R, Wollner PK, Worts K, Sutherland WJ.

PLoS One. 2014 May 30;9(5):e96480. doi: 10.1371/journal.pone.0096480. eCollection 2014.

PMID:
24879444
[PubMed - in process]
Free PMC Article
3.

Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.

Abraham L, Pinkerton JV, Messig M, Ryan KA, Komm BS, Mirkin S.

Maturitas. 2014 Jul;78(3):212-8. doi: 10.1016/j.maturitas.2014.04.008. Epub 2014 Apr 26.

PMID:
24837362
[PubMed - in process]
4.

Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.

Pinkerton JV, Harvey JA, Lindsay R, Pan K, Chines AA, Mirkin S, Archer DF; SMART-5 Investigators.

J Clin Endocrinol Metab. 2014 Feb;99(2):E189-98. doi: 10.1210/jc.2013-1707. Epub 2014 Jan 17.

PMID:
24438370
[PubMed - indexed for MEDLINE]
5.

Evaluation of the measurement model and clinically important differences for menopause-specific quality of life associated with bazedoxifene/conjugated estrogens.

Bushmakin AG, Abraham L, Pinkerton JV, Cappelleri JC, Mirkin S.

Menopause. 2014 Aug;21(8):815-22. doi: 10.1097/GME.0000000000000176.

PMID:
24378765
[PubMed - in process]
6.

Use of SERMs for treatment in postmenopausal women.

Pinkerton JV, Thomas S.

J Steroid Biochem Mol Biol. 2014 Jul;142:142-54. doi: 10.1016/j.jsbmb.2013.12.011. Epub 2013 Dec 25. Review.

PMID:
24373794
[PubMed - indexed for MEDLINE]
7.

Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.

Pinkerton JV, Abraham L, Bushmakin AG, Cappelleri JC, Racketa J, Shi H, Chines AA, Mirkin S.

J Womens Health (Larchmt). 2014 Jan;23(1):18-28. doi: 10.1089/jwh.2013.4392. Epub 2013 Nov 9.

PMID:
24206058
[PubMed - indexed for MEDLINE]
8.

Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause.

Pinkerton JV, Kagan R, Portman D, Sathyanarayana R, Sweeney M; Breeze 3 Investigators.

Menopause. 2014 Jun;21(6):567-73. doi: 10.1097/GME.0b013e3182a7c073.

PMID:
24149930
[PubMed - in process]
9.

Osteoporosis treatment and prevention for postmenopausal women: current and future therapeutic options.

Pinkerton JV, Thomas S, Dalkin AC.

Clin Obstet Gynecol. 2013 Dec;56(4):711-21. doi: 10.1097/GRF.0b013e3182a9fb02. Review.

PMID:
24100598
[PubMed - indexed for MEDLINE]
10.

Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial.

Pinkerton JV, Pan K, Abraham L, Racketa J, Ryan KA, Chines AA, Mirkin S.

Menopause. 2014 Mar;21(3):252-9. doi: 10.1097/GME.0b013e31829f0433.

PMID:
23942245
[PubMed - in process]
11.

Evaluation of the direct and indirect effects of bazedoxifene/conjugated estrogens on sleep disturbance using mediation modeling.

Pinkerton JV, Bushmakin AG, Racketa J, Cappelleri JC, Chines AA, Mirkin S.

Menopause. 2014 Mar;21(3):243-51. doi: 10.1097/GME.0b013e31829f05d1.

PMID:
23899830
[PubMed - in process]
12.

Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.

Pinkerton JV, Komm BS, Mirkin S.

Climacteric. 2013 Dec;16(6):618-28. doi: 10.3109/13697137.2013.810437. Epub 2013 Jun 27.

PMID:
23805785
[PubMed - in process]
13.

Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy.

Pinkerton JV, Stanczyk FZ.

Menopause. 2014 Mar;21(3):309-19. doi: 10.1097/GME.0b013e31829755ed.

PMID:
23777900
[PubMed - in process]
14.

Vulnerability to depression and cardiometabolic risk associated with early ovarian disruption.

Clayton AH, Pinkerton JV.

Menopause. 2013 Jun;20(6):598-9. doi: 10.1097/GME.0b013e3182932cca. No abstract available.

PMID:
23676634
[PubMed - indexed for MEDLINE]
15.

Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment.

Hess R, Huang AJ, Richter HE, Ghetti CC, Sung VW, Barrett-Connor E, Gregory WT, Pinkerton JV, Bradley CS, Kraus SR, Rogers RG, Subak LL, Johnson KC, Arya LA, Schembri M, Brown JS.

Am J Obstet Gynecol. 2013 Sep;209(3):244.e1-9. doi: 10.1016/j.ajog.2013.05.008. Epub 2013 May 6.

PMID:
23659987
[PubMed - indexed for MEDLINE]
16.

Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial.

Pinkerton JV, Harvey JA, Pan K, Thompson JR, Ryan KA, Chines AA, Mirkin S.

Obstet Gynecol. 2013 May;121(5):959-68. doi: 10.1097/AOG.0b013e31828c5974.

PMID:
23635731
[PubMed - indexed for MEDLINE]
17.

Risk of first-time heart disease higher for hormone therapy users with metabolic syndrome.

Pinkerton JV, Pastore LM, Johns DW, Tucker AL.

Menopause. 2013 Mar;20(3):244-7. doi: 10.1097/GME.0b013e3182850c5d. No abstract available.

PMID:
23435018
[PubMed - indexed for MEDLINE]
18.

"People like numbers": a descriptive study of cognitive assessment methods in clinical practice for Aboriginal Australians in the Northern Territory.

Dingwall KM, Pinkerton J, Lindeman MA.

BMC Psychiatry. 2013 Jan 31;13:42. doi: 10.1186/1471-244X-13-42.

PMID:
23368850
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens.

Harvey JA, Pinkerton JV, Baracat EC, Shi H, Chines AA, Mirkin S.

Menopause. 2013 Feb;20(2):138-45. doi: 10.1097/gme.0b013e318271f5e7.

PMID:
23271189
[PubMed - indexed for MEDLINE]
20.

Cardiovascular, cerebrovascular, and hepatic safety of desvenlafaxine for 1 year in women with vasomotor symptoms associated with menopause.

Archer DF, Pinkerton JV, Guico-Pabia CJ, Hwang E, Cheng RF; Study 3353 Investigators.

Menopause. 2013 Jan;20(1):47-56. doi: 10.1097/gme.0b013e3182775fe9.

PMID:
23266840
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk